LTBR and neoplasm: This study describes a recombinant mouse LIGHT protein that binds to its receptors (mouse HVEM and LTβR), demonstrates activity in vitro through a cell-based reporter bioassay, and, when expressed by tumor cells, enhances anti-tumor activity in vivo in a poorly immunogenic cold tumor model by promoting immune cell infiltration.